FLSM
NAMS icon

Frazier Life Sciences Management’s NewAmsterdam Pharma NAMS Stock Holding History

Frazier Life Sciences Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$542M Hold
16,943,774
– – 13.96% 2
2025
Q4 		$594M Buy
16,943,774
+241,818
+1% +$8.8M 15.96% 1
2025
Q3 		$475M Buy
16,701,956
+94,882
+0.6% +$2.27M 14.23% 2
2025
Q2 		$301M Buy
16,607,074
+490,656
+3% +$8.95M 12.03% 3
2025
Q1 		$330M Buy
16,116,418
+200,000
+1% +$4.45M 15.08% 1
2024
Q4 		$409M Buy
15,916,418
+3,061,224
+24% +$65M 16.98% 1
2024
Q3 		$213M Buy
12,855,194
+628,251
+5% +$10.9M 8.55% 2
2024
Q2 		$235M Hold
12,226,943
– – 10.99% 1
2024
Q1 		$289M Buy
12,226,943
+95,238
+0.8% +$1.93M 12.2% 1
2023
Q4 		$136M Hold
12,131,705
– – 7.25% 3
2023
Q3 		$112M Buy
12,131,705
+1,259,902
+12% +$13.6M 7.45% 4
2023
Q2 		$129M Buy
10,871,803
+1,530,252
+16% +$20.3M 7.72% 4
2023
Q1 		$126M Hold
9,341,551
– – 9.09% 2
2022
Q4 		$102M Buy
+9,341,551
New +$92.8M 6.33% 5

Other funds holding NAMS

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return